Buy, Sell or Hold: AbCellera Biologics (ABCL-Q) — Stock Predictions at Stockchase

NASDAQ:ABCL

8.57

0.07 (0.81%) 1d

Showing 1 to 2 of 2 entries

DON'T BUY

This biotech is purely speculative. He ain't playin'.

biotechnology

RISKY BUY

It's a spec play, but he likes the biologics space.

biotechnology

Showing 1 to 2 of 2 entries

AbCellera Biologics(ABCL-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for AbCellera Biologics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

AbCellera Biologics(ABCL-Q) Frequently Asked Questions

What is AbCellera Biologics stock symbol?

AbCellera Biologics is a American stock, trading under the symbol ABCL-Q on the NASDAQ (ABCL). It is usually referred to as NASDAQ:ABCL or ABCL-Q

Is AbCellera Biologics a buy or a sell?

In the last year, 2 stock analysts published opinions about ABCL-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for AbCellera Biologics.

Is AbCellera Biologics a good investment or a top pick?

AbCellera Biologics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for AbCellera Biologics.

Why is AbCellera Biologics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is AbCellera Biologics worth watching?

2 stock analysts on Stockchase covered AbCellera Biologics In the last year. It is a trending stock that is worth watching.

What is AbCellera Biologics stock price?

On 2022-01-24, AbCellera Biologics (ABCL-Q) stock closed at a price of $8.57.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.